Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Congested OTC Monograph Process Can Leave Manufacturers Confused

This article was originally published in The Tan Sheet

Executive Summary

The disparity between FDA's OTC monographs and up-to-date communications from the agency can create confusion for manufacturers, Office of New Drugs Director John Jenkins acknowledges
Advertisement

Related Content

Sea Changes In Regulation And The Market: Top Stories Of 2008
Sea Changes In Regulation And The Market: Top Stories Of 2008
Sea Changes In Regulation And The Market: Top Stories Of 2008
FDA Working Group Considering Changes To OTC Cough/Cold Monograph
Data Support Phenylephrine Efficacy, But More Studies Needed – NDAC
Waxman Bill Would Alter OTC Ad Rules, Streamline FDA Monograph Authority
Infant Cold Products Pulled; Waxman Looks For More OTC Risks
FDA’s Labeling Changes For OTC Pain Relievers Need Flexibility – CHPA
Citizen Petition On Phenylephrine Requests Pulling OTC Status For Children
Citizen Petition On Phenylephrine Requests Pulling OTC Status For Children

Topics

Advertisement
UsernamePublicRestriction

Register

PS101840

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel